654-2穴位注射加妈咪爱对轮状病毒肠炎的疗效

An obseration of therapentic effect of combination treatment for infants with rotavirus gastroenteritis with 654-2 point injection and oral administration of MAMIAI

目的观察654-2穴位注射加口服妈咪爱配合治疗轮状病毒性肠炎的疗效。方法对疑似轮状病毒性肠炎患儿的大便用酶联免疫吸附试验(ELISA)检测轮状病毒抗原,阳性者按照入院单双日分为实验-对照两组。对照组采用补液、抗病毒、对症等常规治疗,实验组在补液的基础上,采用654-2穴位注射同时口服妈咪爱散剂治疗。观察两组治疗前后大便性状、次数。结果实验组有效率和总有效率分别为63.9%(23/36)和86.1%(31/36),明显高于对照组的39.5%(15/38)和63.2(24/38)(P<0.05);止泻时间实验组为3.18±1.73天,对照组为4.22±1.86天(P<0.05);平均住院日实验组为4.14±1.23天,短于对照组的5.23±1.47天(P<0.05)。结论配合使用654-2穴位注射加口服妈咪能提高轮状病毒性肠炎的疗效。

Objective To observe the effect of combination treatment with 654-2 point injection and oral administration of MAMIAI for infants with rotavirus gastroenteritis. Methods ELISA was used to detect the rotavirus antigen in feces of infants who were suspected to suffer from rotavirus gastroenteritis. According to the odd day or even day at which the infants admitted, the positive infants were divided into two groups： the experiment group and the contrast group. The infants in the experiment group were treated by fluid infusion combined with 654-2 point injection and oral administration of MAMIAI powder, the infants in the contrast group were treated by conventional therapies such as fluid infusion, anti-virotherapy, symptomatic treatment. The changes in frequency and character of feces of infants in the two groups were observated before and after treatment. Results The effective rate and total effective rate of patients in the experiment group were 63.9% （23/36） and 86.1% （31/36）respoctively, while those of patients in the contrast group were 39.5% （ 15/38）and 63.2（24/ 38） respectively, and there was significant difference（P 〈0.05）. The antidiarrheal time were 3.18 ± 1.73 days in the experiment group and 4.22 ± 1.86days in the contrast group （P 〈0.05）. The average hospitalizations was 4.14 ± 1.23 days in the experiment group, which was shorter than that in contrast group （5.23 ± 1.47 days） （ P 〈 0.05 ）. Conclusion The combination treatment with 654-2 point injection and oral administration of MAMIAI can improve the curative effect of patients with rotavirus gastroenteritis.